Research
Hormonal
GLP-1 receptor agonists (GLP-1RAs) are effective for reducing body weight and are approved for the treatment of obesity.
GLP-1RAs can be considered as a treatment option for patients struggling with obesity.
StrongSupportsmedium confidence
The GLP-1 receptor agonists (GLP-1RAs) were developed primarily for T2DM and they also reduce body weight.
Why this rating
The claim is based on established approvals and clinical use.
Source
Investigational glucagon-like peptide-1 agonists for the treatment of obesity
Brian Tomlinson et al. · Expert Opinion on Investigational Drugs · 2016
reviewCited 24×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →